ArticleJournal of Korean medical science2026
Evaluation of the Medical Utilization of the Telemedicine Pilot Project for Patients With Diabetes Based on Korean National Health Insurance Claims Data.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundNumerous studies have explored blood sugar management in patients with diabetes through telemedicine. However, since the implementation of the telemedicine pilot project, no studies have assessed changes in healthcare utilization for diabetes. This study examined medical outcomes and utilization among diabetes patients comparing telemedicine to traditional in-person care, focusing on medical utilization, care continuity, prescription adherence, and safety.
methodsThis study used data from the National Health Insurance Service to identify patients with diabetes who did or did not receive telemedicine. We analyzed medical utilization, medical sustainability, prescription continuity, and safety through propensity score matching (PSM). To evaluate the telemedicine pilot project's impact, changes and differences in outcome indicators were calculated using a Difference-in-Differences (DID) approach.
resultsAfter PSM, the total number of patients in the telemedicine group (Tele_G) and the face-to-face treatment group (Control_G) was 59,954 each. Medical utilization of telemedicine decreased in both groups, but the DID was 0.16 (-0.04 in Tele_G vs. -0.20 in Control_G,
conclusionDID analysis revealed the potential of the telemedicine pilot project, with slightly lower continuity than face-to-face care; hence, it is acceptable as a supplementary service. To improve this, a telemedicine system specializing in diabetes and blood glucose management is needed, along with a clear protocol that allows patient blood glucose data to be integrated into the telemedicine platform.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.